Condition-Specific Health
Fight CRC Expands Climb for a Cure Nationwide on July 18
The expanded virtual format broadens reach for a cause increasingly linked to diet, fiber intake, and gut-health resear…
Condition-Specific Health 100 stories
Condition-Specific Health
Beacon Biosignals Rebrands Sleep Diagnostics Portfolio Under One Name
The move reflects growing operator demand for streamlined sleep-health platforms as the at-home diagnostics category co…
Condition-Specific Health
Gain Therapeutics CEO to Present at Neuro Summit
The clinical-stage biotech is advancing allosteric small molecule therapies — a mechanism drawing growing interest from…
Condition-Specific Health
CONNECTA Therapeutics Advances CTH120 Neuroplasticity Trial
The rare CNS indication sits outside core nutraceutical channels, but neuroplasticity modulation is an emerging mechani…
Condition-Specific Health
Migraine Awareness Campaign Targets Stigma Affecting Millions
As migraine prevalence fuels demand for magnesium, riboflavin, and CoQ10 formulations, advocacy efforts may accelerate …
Condition-Specific Health
Nucleus Genomics Expands IVF+ Network to Hawaii and Asia-Pacific
The network expansion signals growing operator demand for genomic optimization tools at the clinical fertility interfac…
Condition-Specific Health
Nucleus IVF+ Network Adds Hawaii Clinic Amid Embryo Genomics Demand
The partnership signals growing operator interest in genomics-adjacent reproductive health services as precision nutrit…
Condition-Specific Health
Nucleus IVF+ Network Expands to Hawaii Amid Genetic Testing Demand
The partnership signals growing operator demand for genetic optimization services within assisted reproduction — a cate…
Condition-Specific Health
PRM and Project Endo Target Campus Health with Endo Screening Push
An estimated 1 in 10 women of reproductive age live with endometriosis — a condition averaging a 7–10 year diagnostic d…
Condition-Specific Health
BrainsWay SWIFT Deep TMS Posts 80% Remission Rate at 12 Months
Preliminary durability data presented at the Clinical TMS Society Annual Meeting signal a potential shift in how device…
Condition-Specific Health
TG Therapeutics SC BRIUMVI Shows 82% MCID Rate in Myasthenia Gravis Phase 1
TG Therapeutics advances to a potential registration-directed Phase 2 trial as subcutaneous delivery format targets imp…
Condition-Specific Health
Invivyd Launches Phase 3 Trial for VYD2311 mAb COVID Prevention
Topline data from the randomized, double-blind LIBERTY study is expected in Q3 2026, alongside results from the pivotal…